Denis Angioletti
Directeur/Membre du Conseil chez LIPIDOR AB
Provenance du réseau au premier degré de Denis Angioletti
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Miscellaneous Commercial Services | 9 | |
Cerbios-Pharma SA
 Cerbios-Pharma SA Pharmaceuticals: MajorHealth Technology Cerbios-Pharma SA develops and manufactures pharmaceutical ingredient. Its products include drug substances and products, and animal health feed. The company was founded in 1994 and is headquartered in Barbengo – Lugano, Switzerland.
5
| Private Company | Pharmaceuticals: Major | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Denis Angioletti via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
| ZICCUM AB | Medical Specialties | Corporate Officer/Principal Chairman Director of Finance/CFO | |
| ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member Public Communications Contact Comptroller/Controller/Auditor | |
| INHALATION SCIENCES SWEDEN AB | Medical Specialties | Director of Finance/CFO Chief Executive Officer Director of Finance/CFO | |
| CHORDATE MEDICAL HOLDING AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ECTIN RESEARCH AB | Biotechnology | Chairman Director of Finance/CFO | |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KD Incentive AB | Director/Board Member Director/Board Member | ||
| Sumit System AB | Chief Executive Officer Chairman | ||
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| Emollivet AB | Chairman Director of Finance/CFO | ||
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chairman Corporate Officer/Principal | |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor Private Equity Investor | |
| Royal Institute of Technology | College/University | Graduate Degree Doctorate Degree | |
| KCIF Fund Management AB | Chief Executive Officer Chief Executive Officer | ||
| Chalmers University of Technology | College/University | Graduate Degree Graduate Degree | |
| MODUS THERAPEUTICS HOLDING AB | Biotechnology | Director/Board Member Director/Board Member | |
Vitamex AB
 Vitamex AB Pharmaceuticals: MajorHealth Technology Vitamex AB develops and manufactures pharmaceutical products. It is licensed to produce VMS products, nutraceuticals, OTC products, and Rx pharmaceuticals. The company manufactures cosmetics, anti-oxidants, minerals, and vitamins. Its products include drugs for anxiety, pain, cold & flu, indigestion, weight management, cardiovascular diseases, and hair, skin as well as nails-related problems. Vitamex was founded in 1986 and is headquartered in Norrköping, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO | |
| MONIVENT AB | Medical Specialties | Chairman | |
| Bactaviva AB | Director/Board Member | ||
| BIO VITOS PHARMA AB | Medical Specialties | Chief Executive Officer | |
| Axelero AB | Director/Board Member | ||
| Phargentis AB | Director/Board Member | ||
| Swedish Society For Nature Conservation | Chairman | ||
RespiNor AS
 RespiNor AS Electronic Equipment/InstrumentsElectronic Technology RespiNor AS operates as a medical device company. The company is headquartered in Oslo, Norway. | Electronic Equipment/Instruments | Director/Board Member | |
| Pharmacia Upjohn | Corporate Officer/Principal | ||
Novozymes Biopharma Sweden AB
 Novozymes Biopharma Sweden AB BiotechnologyHealth Technology Part of Repligen Corp., Novozymes Biopharma Sweden AB operates as a contract manufacturer of biological products. The company is based in Lund, Sweden. The CEO of the Swedish company is Harald Skogman. Novozymes Biopharma Sweden was acquired by Repligen Corp. from Novozymes A/S on December 20, 2011 for $29.02 million. | Biotechnology | Corporate Officer/Principal | |
Q-Med AB
 Q-Med AB Medical SpecialtiesHealth Technology Q-Med AB specializes in aesthetic and corrective solutions. It develops and manufactures brand management for aesthetic and corrective treatments, whereas its portfolio is based on the company’s patented technology, NASHA, for the production of stabilise of non-animal hyaluronic acid. The firm offers portfolio including the brands Restylane, Emervel, Azzalure, Dysport, Deflux, Solesta, and Durolane are other products improving patients’ health in the corrective field. The company was founded by Bengt Agerup on June 17, 1985 and is headquartered in Uppsala, Sweden. | Medical Specialties | Corporate Officer/Principal | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
Viseca Payment Services AG
 Viseca Payment Services AG Finance/Rental/LeasingFinance Viseca Payment Services AG engages in the provision of cashless payment and private financing services. The firm operates payment, customer finance and synergies divisions. It offers credit and pre-paid cards, commercial customers payment terminals and point-of-sale services, lease financing and private loans to individual and retailing customers. The company was founded in 1999 and is headquartered in Zurich, Switzerland. | Finance/Rental/Leasing | Director/Board Member | |
Cobra Biologics Holding AB
 Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Stockholm | College/University | Doctorate Degree | |
International University of Monaco
 International University of Monaco Other Consumer ServicesConsumer Services The Monaco Business School at the International University of Monaco (IUM) develops successful and thoughtful leaders and entrepreneurs. They are the only university which provides a business education fully taught in English on the Cote D'Azur. With 60 nationalities represented in the student body and faculty, it is the premier institution for higher education in the Principality of Monaco. There is a high-level of interactivity between professors and students, and they encourage innovative and creative thinking. They encourage students to go beyond the theories and data taught in the lecture hall by using the skills learnt in real world situations. This allows them to develop strong analytical and cognitive skills which provide them with a foundation for their development as successful business people. Students learn in a thoroughly multi-cultural environment, which brings together people from all over the world to share ideas, change lives and create opportunities on a global scale. Their students take with them a sense of who they are in the world of commerce, and pride in themselves as confident business people and entrepreneurs of tomorrow. Their students graduate with the business skills, practical experience and personal development that will serve them for life. | College/University | Undergraduate Degree | |
Kibion AB
 Kibion AB Medical SpecialtiesHealth Technology Kibion AB manufactures and distributes medical test and analytical instruments. It provides solutions for rapid urea breath tests for diagnosing the stomach ulcer bacterium Helicobacter pylori. The firm offers products such as Heliprobe System, Diabact Urea Breath Test, and Kibion Dynamic. The company was founded in 2005 and is headquartered in Uppsala, Sweden. | Medical Specialties | Sales & Marketing | |
| ACOSENSE AB (PUBL) | Electronic Equipment/Instruments | Director of Finance/CFO | |
| Offshoreväst | Corporate Officer/Principal | ||
| Ecoera | Chief Executive Officer | ||
| Ocean Energy Centre | Corporate Officer/Principal | ||
| University of Gothenburg | College/University | Graduate Degree | |
| MINESTO AB | Alternative Power Generation | Chief Operating Officer | |
| ONCOZENGE AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| Isles of Wines AB | Chief Executive Officer | ||
| Lecra AB | Director/Board Member | ||
| Dizlin Pharmaceuticals AB | Comptroller/Controller/Auditor | ||
| LIPIGON PHARMACEUTICALS AB | Pharmaceuticals: Major | Director of Finance/CFO | |
| Lecra Eco Sustain AB | Director/Board Member |
Statistiques
Internationale
| Suède | 45 |
| Norvège | 3 |
| Danemark | 2 |
| Suisse | 2 |
| Monaco | 2 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 6 |
| Finance | 4 |
| Commercial Services | 3 |
| Electronic Technology | 3 |
Opérationnelle
| Director/Board Member | 66 |
| Chairman | 20 |
| Corporate Officer/Principal | 19 |
| Chief Executive Officer | 16 |
| Director of Finance/CFO | 15 |
Relations les plus connectées
- Bourse
- Insiders
- Denis Angioletti
- Connexions Sociétés
